Clinical Trial Update: Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating oxaliplatin, 5-FU, and leucovorin with oral capecitabine for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Capecitabine (capecitabine)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED